View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
September 6, 2018

Philips releases new TissueMark computational pathology software

Health technology major Royal Philips has introduced an updated version of its TissueMark computational pathology solution software at Euskalduna Conference Centre in Bilbao, Spain.

Health technology major Royal Philips has introduced an updated version of its TissueMark computational pathology solution software at Euskalduna Conference Centre in Bilbao, Spain.

The new TissueMark version leverages artificial intelligence (AI) to support region of interest detection for molecular testing as well as assists research labs in enhancing the accuracy of tumour estimation.

It will also offer tumour sufficiency guidance for lung histology, lung cytology, colon and breast tissue samples along with whole slide images (WSI) of adenocarcinoma prostate tissue as well as high-grade serous carcinoma ovarian tissue.

“The new TissueMark version leverages artificial intelligence to support region of interest detection for molecular testing as well as assists research labs in enhancing the accuracy of tumour estimation.”

Philips digital and computational pathology general manager Marlon Thompson said: “Using a microscope for tumour estimation is subjective and leads to high variability amongst pathologists.

“By digitising the tissue slide and analysing the image with robust computational software and intelligent algorithms, we can better support pathologists’ workflows and help labs enhance quality and reliability while reducing costs by limiting the number of molecular tests performed with insufficient tumour content.”

In addition, the company aims to support pathologists’ workflows by digitising the tissue slide and uses computational software and intelligent algorithms to analyse the image.

This will assist labs to improve quality and reliability as well as reduce costs by limiting the number of molecular tests performed with insufficient tumour content.

Earlier this year, the technology company unveiled its AI platform for healthcare.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network